Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman

Endocrine Pathology

Volumn 20, Issue 1, 2009, Pages 66-72

  Shigematsu, Kazuto ^a,b   Nishida, Noriyuki ^b   Sakai, Hideki ^b   Igawa, Tsukasa ^b   Suzuki, Shin ^c   Kawai, Kioko ^d   Takahara, Osamu ^a  

^a JAPANESE RED CROSS SOCIETY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d Nagasaki Prefecture Medical Health Operation Group   (Japan)

Author keywords

ACTH; Aldosterone producing adenoma; Pregnancy; Primary aldosteronism; Sex steroid hormone receptor; Zona glomerulosa type cells

Indexed keywords

ALDOSTERONE SYNTHASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOCHROME P450; CYTOCHROME P450 11B1; CYTOCHROME P450 17A1; CYTOCHROME P450 21A2; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; MELANOCORTIN 2 RECEPTOR; POTASSIUM; STEROIDOGENIC ACUTE REGULATORY PROTEIN; UNCLASSIFIED DRUG; ALDOSTERONE; MESSENGER RNA;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE SECRETING ADENOMA; ARTICLE; CASE REPORT; CESAREAN SECTION; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOKALEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL EDEMA; PREGNANT WOMAN; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; ZONA GLOMERULOSA; ADRENAL CORTEX TUMOR; BIOSYNTHESIS; BLOOD; HYPERALDOSTERONISM; METABOLISM; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ADULT; ALDOSTERONE; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTOR, MELANOCORTIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ZONA GLOMERULOSA;

EID: 66349103398     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-009-9060-8     Document Type: Article

References (24)

1. Kosaka K, Onoda N, Ishikawa T, Iwanaga N, Yamamasu S, Tahara H, Inaba M, Ishimura E, Ogawa Y, Hirakawa K. Laparoscopic adrenalectomy on a patient with primary aldosteronism during pregnancy. Endcr J 53:461-466, 2006 doi:10.1507/ endocrj.K05-122.
2. August P, Lindheimer MD. Hypertension in pregnancy. In: Kaplan NM, et al, ed. Individualized therapy of hypertension. New York: Marcel Dekker, pp. 165-193, 1995.
3. Wilson M, Morganti AA, Zervoudakis I, Letcher RL, Romney BM, Von Oeyon P, Papera S, Sealey JE, Laragh JH. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 68:97-104, 1980 doi:10.1016/ 0002-9343(80)90178-90183
4. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 86:1066-1071, 2001 doi:10.1210/jc.86.3.1066. (Pubitemid 32322983)
5. Neville AM, O'Hare MJ. Hyperaldosteronism and related syndromes of mineralocorticoid excess. In: Neville AM, et al, ed. The human adrenal cortex. Berlin: Springer, pp. 202-241, 1982.
6. Shigematsu K, Nakagaki T, Yamaguchi N, Kawai K, Sakai H, Takahara O. Analysis of mRNA expression for steroidogenic enzymes in the remaining adrenal cortices attached to adrenocortical adenomas. Eur J Endocrinol 158:867-78, 2008 doi:10.1530/ EJE-07-0626.
7. Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202-206, 1989.
8. Okawa T, Asano K, Hashimoto T, Fujimori K, Yanagida K, Sato A. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. Am J Perinatol 19:31-36, 2002 doi:10.1055/s-2002-20170.
9. Laidlaw JC, Ruse JL, Gornall AG. The influence of estrogen and progesterone on aldosterone excretion. J Clin Endocrinol Metab 22:161-171, 1962.
10. Casey ML, MacDonald PC, Simpson ER. Endocrinological changes of pregnancy. In: Wilson JD, et al, ed. Williams textbook of endocrinology. 8th ed. Philadelphia: Saunders, pp. 977-991, 1996.
11. Aiba M, Fujibayashi M. Histopathological diagnosis and prognostic factors in adrenocortical carcinoma. Endocr Pathol 16:13-22, 2005 doi:10.1385/EP:16:1: 013.
12. Dobbie JW. Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 99:1-18, 1969 doi:10.1002/path.1710990102.
13. Schmitt A, Saremaslani P, Schmid S, Rousson V, Montani M, Schmid DM, Heitz PU, Komminoth P, Perren A. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Histopathology 49:298-307, 2006 doi:10.1111/j.1365-2559.2006.02505.x. (Pubitemid 44253620)
14. Keegan GT, Grabarits F, Roland AS. Pregnancy complicated by Cushing's syndrome. South Med J 69:1207-1209, 1976.
15. Allolio B, Reincke M. Adrenocorticotropin receptor and adrenal disorders. Horm Res 47:273-278, 1997 doi:10.1159/000185476.
16. de Cremoux P, Rosenberg D, Goussard J, Brémont-Weil C, Tissier F, Tran-Perennou C, Groussin L, Bertagna X, Bertherat J, Raffin- Sanson ML. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease. Endocr Relat Cancer 15:465-474, 2008 doi:10.1677/ERC-07-0081. (Pubitemid 351880835)
17. Chida D, Nakagawa S, Nagai S, Sagara H, Katsumata H, Imaki T, Suzuki H, Mitani F, Ogishima T, Shimizu C, Kotaki H, Kakuta S, Sudo K, Koike T, Kubo M, Iwakura Y. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc Natl Acad Sci U S A 104:18205-18210, 2007 doi:10.1073/pnas.0706953104. (Pubitemid 350210845)
18. Sewer MB, Waterman MR. ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex. Microsc Res Tech 61:300-307, 2003 doi:10.1002/ jemt.10339.
19. Georgiadou D, Sergentanis TN, Kostopoulou A, Zografos GN, Papastratis G. Estrogen receptors alpha and beta in adrenal cortical neoplasia: heterogeneity and physiological implications. Virchows Arch 452:181-191, 2008 doi:10.1007/s00428-007-0542-0.
20. Albrecht ED, Babischkin JS, Davies WA, Leavitt MG, Pepe GJ. Identification and developmental expression of the estrogen receptor alpha and beta in the baboon fetal adrenal gland. Endocrinology 140:5953-5961, 1999 doi:10.1210/en.140.12.5953.
21. Montanaro D, Maggiolini M, Recchia AG, Sirianni R, Aquila S, Barzon L, Fallo F, Andò S, Pezzi V. Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation. J Mol Endocrinol 35:245-256, 2005 doi:10.1677/jme.1.01806. (Pubitemid 41556173)
22. Bassett MH, Mayhew B, Rehman K, White PC, Mantero F, Arnaldi G, Stewart PM, Bujalska I, Rainey WE. Expression profiles for steroidogenic enzymes in adrenocortical disease. J Clin Endocrinol Metab 90:5446-55, 2005 doi:10.1210/jc.2005- 0836. (Pubitemid 41262314)
23. Shigematsu K. Comparative studies between hormone contents and morphological appearances in human adrenal cortex-special reference to non-functioning tumors (adenoma and adenomatous nodule) and functioning adenoma. Acta Histochem Cytochem 15:386-400, 1982.
24. Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism 51:350-355, 2002 doi:10.1053/meta.2002.30498. (Pubitemid 34232637)